Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Immunology Letters|February 12, 2013
Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergyPinya Pulsawat, Patrawadee Pitakpolrat, Eakachai Prompetchara, et al.Neuro-Degenerative Diseases|February 4, 2012
Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responsesHayk Davtyan, Anahit Ghochikyan, Nina Movsesyan, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 7, 2013
Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaquesClaire F Evans, Hayk Davtyan, Irina Petrushina, et al.Journal of Virology|January 24, 2014
Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primatesThomas Grunwald, Matthias Tenbusch, Reiner Schulte, et al.Vaccine|November 25, 2010
Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporationKaren E Dolter, Claire F Evans, Barry Ellefsen, et al.Vaccine|July 31, 2010
Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodiesSylvia van Drunen Littel-van den Hurk, Zoe Lawman, Don Wilson, et al.Vaccine|July 23, 2009
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun deliverySimon R Best, Shiwen Peng, Chi-Mou Juang, et al.Clinical and Vaccine Immunology : CVI|December 11, 2012
Two doses of bovine viral diarrhea virus DNA vaccine delivered by electroporation induce long-term protective immune responsesSylvia van Drunen Littel-van den Hurk, Zoe Lawman, Marlene Snider, et al.Viruses|February 21, 2019
Glycosylation of HIV Env Impacts IgG Subtype Responses to VaccinationRebecca Heß, Michael Storcksdieck Genannt Bonsmann, Dennis Lapuente, et al.Cancer Immunology, Immunotherapy : CII|September 27, 2012
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccineShiwen Peng, Sofia Lyford-Pike, Belinda Akpeng, et al.Pageof 6